natgillin/translations-raw huggingface dataset:
Concomitant use of sildenafil for the treatment of erectile dysfunction with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer should be with caution and in no instance should sildenafil doses exceed 25 mg in 48 hours (see also section 4.4). 
Pri primjeni sildenafila za liječenje erektilne disfunkcije istodobno s ritonavirom doziranim kao antiretrovirusnim lijekom ili kao farmakokinetičkim pojačivačem nužan je oprez, a sildenafil se ni u kojem slučaju ne smije davati u dozama većima od 25 mg u 48 sati (vidjeti i dio 4.4).
- Atorvastatin or rosuvastatin (for high cholesterol) as Norvir may raise the blood levels of these medicines. 
Atorvastatin ili rosuvastatin (za visok kolesterol), jer Norvir može povisiti razine tih lijekova u krvi.
How do I take the correct dose of Norvir powder for oral suspension mixed with liquid? 
Norvir praška za oralnu suspenziju pomiješanog s tekućinom?
The interaction profiles of HIV-protease inhibitors, co-administered with low dose ritonavir, are dependant on the specific co-administered protease inhibitor. 
Profil interakcija inhibitora HIV-proteaza, kada se daju istodobno s ritonavirom u malim dozama, ovisi o određenom inhibitoru proteaza koji se daje.
↑ 49-fold 
↑ 49 puta
Treatment should be initiated at 300 mg (three sachets) twice daily for a period of three days and increased by 100 mg (one sachet) twice daily increments up to 600 mg twice daily over a period of no longer than 14 days. 
Liječenje treba početi dozom od 300 mg (tri vrećice) dva puta na dan tijekom tri dana, a potom dozu tijekom razdoblja ne dužeg od 14 dana povećavati za po 100 mg (jedna vrećica) dva puta na dan sve do 600 mg dva puta na dan.
• inflammation of the liver and yellowing of skin or whites of the eyes 
• upala jetre i žuta boja kože ili bjeloočnica • učestalije mokrenje
500 q12h, 10 
500 svakih 12h, 10 dana
- The active substance is ritonavir. 
Djelatna tvar je ritonavir.
Barrier or other non-hormonal methods of contraception should be considered when administering ritonavir at therapeutic or low doses as ritonavir is likely to reduce the effect and change the uterine bleeding profile when co-administered with estradiol-containing contraceptives. 
Pri primjeni ritonavira u terapijskim ili malim dozama treba razmotriti korištenje mehaničkih i ostalih nehormonskih metoda kontracepcije jer bi ritonavir vjerojatno oslabio djelovanje etinilestradiola i promijenio profil uterinog krvarenja kada bi se uzimao istodobno s kontraceptivima koji sadržavaju estradiol.
− pethidine, piroxicam, propoxyphene (used to relieve pain); 
− petidin, piroksikam, propoksifen (koriste se za ublažavanje boli);
Decreased R-warfarin levels may lead to reduced anticoagulation, therefore it is recommended that anticoagulation parameters are monitored when warfarin is coadministered with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer. 
Zbog sniženih razina R-varfarina može oslabiti antikoagulacijski učinak te se stoga preporučuje praćenje koagulacijskih parametara kada se varfarin daje istodobno s ritonavirom doziranim kao antiretrovirusnim lijekom ili kao farmakokinetičkim pojačivačem.
Amprenavir1 ↑ 64% ↑ 5 fold 
100 svakih 12h Amprenavir1 ↑ 64% ↑ 5 puta
Norvir is also supplied as a powder for oral suspension containing 100 mg of ritonavir. 
Norvir dolazi i u obliku praška za oralnu suspenziju koji sadrži 100 mg ritonavira.
Didanosine 200 q12h 
Didanozin 200 svakih 12h
− Multipack containing 90 (3 bottles of 30) film-coated tablets 
Višestruko pakiranje sadrži 90 (3 boce sa 30) filmom obloženih tableta
Medicinal 
Liječenje
Norvir 100 mg film-coated tablets ritonavir 
Norvir 100 mg filmom obložene tablete ritonavir
Polyethylene/aluminium/polyethylene terephthalate foil sachet. 
Vrećica od polietilen/aluminij/polietilen tereftalatne folije. 30 vrećica u kutiji.
Increased plasma concentrations of avanafil (see section 4.4. and 4.5). 
Povišena koncentracija avanafila u plazmi (vidjeti dio 4.4 i 4.5).
A controlled study completed in 1996 with ritonavir as add-on therapy in HIV-1 infected patients extensively pre-treated with nucleoside analogues and baseline CD4 cell counts ≤ 100 cells/µl showed a reduction in mortality and AIDS defining events. 
Kontrolirano ispitivanje dovršeno 1996. godine, s ritonavirom kao dopunskim lijekom u liječenju bolesnika s HIV-1 infekcijama prethodno opsežno liječenima analozima nukleozida i s brojem CD4
− heart medicines (e.g. disopyramide, mexiletine and calcium channel antagonists such as amlodipine, diltiazem and nifedipine); 
− lijekove za srce (npr. dizopiramid, meksiletin i antagonisti kalcijevih kanala, poput amlodipina,
When ritonavir is used as a pharmacokinetic enhancer, full details on the warnings and precautions relevant to that particular PI must be considered, therefore the Summary of Product Characteristics, section 4.4, for the particular PI must be consulted to determine if the information below is applicable. 
Kada se ritonavir daje kao farmakokinetički pojačivač, nužno je potanko se upoznati sa svim upozorenjima i mjerama opreza za određeni IP te se stoga mora pročitati njihov Sažetak opisa svojstava lijeka i dio 4.4, da se vidi vrijede li niže navedene informacije.
Ritonavir should not be given as a pharmacokinetic enhancer to patients with decompensated liver disease (see section 4.3). 
Ritonavir se ne smije davati kao farmakokinetički pojačivač bolesnicima s dekompenziranom bolešću jetre (vidjeti dio 4.3).
• severe or life threatening skin reaction including blisters (Stevens Johnson syndrome, toxic epidermal necrolysis) 
uključujući pojavu mjehurića (StevensJohnsonov sindrom, toksična epidermalna nekroliza)
Medicinal product interactions - Ritonavir with antiretroviral agents other than protease inhibitors 
Interakcije lijekova - ritonavir s antiretroviroticima koji nisu inhibitori proteaza
500 q12h ↓ 20% / ↑ 20% ↔ 
400 svakih 12h ↓ 82%
526 mg (52.6 ml) twice daily 
526 mg (52,6 ml) dva puta na dan
20, single dose 
20, jednokratna doza
− morphine and morphine-like medicines used to treat severe pain (e.g. methadone, fentanyl); 
− levotiroksin (koristi se za liječenje problema štitnjače); − morfin i njemu slične lijekove, koji se koriste za liječenje jake boli (npr. metadon, fentanil);
− Norvir is not a cure for HIV infection or AIDS. 
Norvir nije lijek za izlječenje HIV-infekcije ni AIDS-a.
200 q12h, 2 days 
200 svakih 12h, 2 dana
Measure the liquid a. Keep the syringe pointed up. 
Slika 3. Izmjerite tekućinu a.
Norvir is also supplied as a film-coated tablet containing 100 mg ritonavir. 
Norvir dolazi i u obliku filmom obloženih tableta koje sadrže 100 mg ritonavira.
Immunosupressants 
Imunosupresivi
Amiodarone, bepridil, dronedarone, encainide, flecanide, propafenone, quinidine 
Amiodaron, bepridil, dronedaron, enkainid, flekanid, propafenon, kinidin
HCV Direct Acting Antiviral 
Direktno djelujući antivirotici za liječenje HCV-a
You must not take Norvir with sildenafil if you suffer from pulmonary arterial hypertension (see also section 2. 
Ako bolujete od plućne arterijske hipertenzije, Norvir ne smijete uzimati istodobno sa sildenafilom (pogledajte i dio 2.
Ritonavir co-administration is likely to result in increased plasma concentrations of amiodarone, bepridil, dronedarone, encainide, flecainide, propafenone, and quinidine and is therefore contraindicated (see section 4.3). 
Istodobno primijenjeni ritonavir vjerojatno povećava koncentracije amiodarona, bepridila, dronedarona, enkainida, flekainida, propafenona i kinidina te je stoga je kontraindiciran (vidjeti dio 4.3).
500 q12h ↓ 20% / ↑ 20% ↔ Dose alteration of sulfamethoxazole/trimethoprim during concomitant ritonavir therapy should not be necessary. 
500 svakih 12h Mijenjanje doze sulfametoksazola/trimetoprima nije nužno pri njihovoj istodobnoj primjeni s ritonavirom.
Check the prescription label on the carton or call your doctor or pharmacist if you are not sure. 
Provjerite recept ili kontaktirajte Vašeg liječnika ili ljekarnika za informaciju o broju vrećica ako niste sigurni.
Pharmacokinetic enhancement by ritonavir is based on ritonavir's activity as a potent inhibitor of CYP3A- mediated metabolism. 
Ritonavir doziran kao farmakokinetički pojačivač Pospješivanje farmakokinetike pomoću ritonavira zasniva se na njegovoj aktivnosti kao snažnog inhibitora metabolizma putem CYP3A.
Delavirdine 400 q8h 
Delavirdin 400 svakih 8h 600 svakih 12h
− antidepressants (e.g. amitriptyline, desipramine, fluoxetine, imipramine, nefazodone, 
− antidepresive (npr. amitriptilin, dezipramin, fluoksetin, imipramin, nefazodon, nortriptilin,
Darunavir 600 mg twice daily with ritonavir 100 mg twice daily in antiretroviral treatment (ART) experienced patients. 
Darunavir 600 mg dva puta na dan s ritonavirom 100 mg dva puta na dan u bolesnika koji su već primali antiretrovirusnu terapiju (ART).
- Trazodone (a medicine for depression) as, unwanted effects like nausea, dizziness, low blood pressure and fainting can occur when taken with Norvir. 
− Trazodon (lijek za depresiju), jer se pri njegovu uzimanju s lijekom Norvir mogu javiti nuspojave poput mučnine, omaglice, niskog krvnog tlaka i nesvjestice.
Silica, colloidal anhydrous Polysorbate 80 
koloidni, bezvodni silicijev dioksid, polisorbat 80.
Based on cross-study comparison to 800 mg indinavir three times daily alone. 
Zasniva se na usporedbi među ispitivanjima s 800 mg indinavira triput na dan, u monoterapiji.
Also read the list of medicines under ‘Other medicines and Norvir' for use with certain other medicines which require special care. 
molimo pogledajte i popis lijekova u dijelu „Drugi lijekovi i Norvir“.
800 q12h 
800 svakih 12h
300 q24h 
300 svakih 24h
The co-administration of riociguat with Norvir is not recommended (see section 4.4 and refer to riociguat SmPC). 
Istodobna primjena riocigvata i lijeka Norvir se ne preporučuje (vidjeti dio 4.4 i Sažetak opisa svojstava lijeka za riocigvat).
200 mg in the morning and 200 mg in the evening 
200 mg ujutro i 200 mg navečer
For further dosage recommendations, refer to the product information of other protease inhibitors approved for co-administration with ritonavir. 
Za ostale preporuke o doziranju pročitati uputu o lijeku za druge inhibitore proteaza, odobrene za primjenu u kombinaciji s ritonavirom.
Sulfamethoxazole was co-administered with trimethoprim. 
2.Sulfametoksazol se davao istodobno s trimetoprimom.
Very common Fatigue including asthenia, flushing, feeling hot 
Vrlo često Umor uključujući asteniju, crvenilo uz osjećaj vrućine
− antihistamines (e.g. loratidine, fexofenadine); 
− antihistaminike (npr. loratidin, feksofenadin);
Refer to the ceritinib SmPC for dosage adjustment recommendations. 
Vidjeti Sažetak opisa svojstava lijeka za ceritinib za preporuke vezane uz prilagodbu doze.
Pour the powder into the cup a. Tear open the sachet. 
Slika 5. Uspite prašak u čašu a.
Ritonavir inhibits CYP3A-mediated metabolism of ketoconazole. 
Ritonavir inhibira metabolizam ketokonazola posredovan enzimom CYP3A.
Each tablet contains 100 mg ritonavir. 
Jedna tableta sadrži 100 mg ritonavira.
Low doses of ritonavir have shown profound effects on the pharmacokinetics of other protease inhibitors (and other products metabolised by CYP3A4) and other protease inhibitors may influence the pharmacokinetics of ritonavir (see section 4.5). 
(i ostalih pripravaka koji se metaboliziraju putem CYP3A4), te da drugi inhibitori proteaza mogu utjecati na farmakokinetiku ritonavira (vidjeti dio 4.5).
50, single dose 
50, jednokratna doza
Norvir powder for oral suspension has a lingering aftertaste. 
Norvir prašak za oralnu suspenziju ostavlja okus u ustima neko vrijeme.
Dose of Coadministered Medicinal Product (mg) 
Doza istodobno primijenjenog lijeka (mg)
600 q24h 
600 svakih 24h
Co-administration of encorafenib and ritonavir should be avoided. 
Potrebno je izbjegavati istodobnu primjenu enkorafeniba i ritonavira.
Inform your doctor as soon as possible if you experience any symptoms that suggest an allergic reaction after taking Norvir such as rash, hives or breathing difficulties. 
Jave li se pri uzimanju lijeka Norvir bilo koji simptom koji upućuje na alergijsku reakciju, poput osipa, koprivnjače ili otežanog disanja, o tome što prije obavijestite svog liječnika.
(For caution on parenterally administered midazolam, see section 4.5. 
(Za mjere opreza pri parenteralnoj primjeni midazolama vidjeti dio
Each sachet of Norvir contains 100 mg ritonavir. 
Jedna vrećica lijeka Norvir sadrži 100 mg ritonavira.
Tel: +40 21 529 30 35 
AbbVie SRL Tel: +40 21 529 30 35
In intent to treat analyses, 72% and 36% of patients achieved reduction in plasma HIV-1 RNA of ≤ 400 copies/ml at Week 16 and 104, respectively. 
Intent-to-treat (ITT) analiza pokazala je da se broj kopija HIV-1 RNK smanjio na ≤ 400/ml u 72% bolesnika nakon 16 tjedana, a u 36% bolesnika nakon 104 tjedna.
Cl/F (L/h) 1 Values expressed as geometric means. 
1 Vrijednosti izražene kao geometrijske srednje vrijednosti.
10, single dose 600 q12h ↑ 153% ↑ 55% Inhibition of CYP3A and P-gp lead to increased plasma levels and pharmacodynamic effects of rivaroxaban which may lead to an increased bleeding risk. 
Inhibicija CYP3A i P-gp je rezultirala povećanjem razina u plazmi te povećanjem farmakodinamičkog učinka rivaroksabana što može dovesti do povećanog rizika od krvarenja.
c. The liquid may look cloudy - this is okay. 
Tekućina može biti mutna, ali to je uredu.
Lopinavir co-formulated with ritonavir (lopinavir/ritonavir) 400 mg/100 mg or 800 mg/200 mg. Saquinavir 1000 mg twice daily with ritonavir 100 mg twice daily in ART experienced patients. 
Lopinavir u formulaciji s ritonavirom (lopinavir/ritonavir) 400 mg/100 mg ili 800 mg/200 mg.
Concomitant use of avanafil or vardenafil with ritonavir is contraindicated (see section 4.3). 
Istodobna primjena avanafila ili vardenafila s ritonavirom je kontraindicirana (vidjeti dio 4.3).
c. Slowly pull the plunger back to the 10 ml mark - try not to pull any bubbles into the syringe (see Figure 8). 
Polako vucite klip do oznake od 10 ml pokušajte ne uvući mjehuriće u štrcaljku
Modest prolongation of the PR interval was also noted in subjects receiving ritonavir in the same study on Day 3. 
U ispitanika koji su primali ritonavir u istom je ispitivanju trećeg dana uočeno i umjereno produženje
Due to the risk of QTc prolongation associated with DM-6705, if co-administration of delamanid with ritonavir is considered necessary, very frequent ECG monitoring throughout the full delamanid treatment period is recommended (see section 4.4 and refer to the delamanid Summary of Product Characteristics). 
Zbog rizika od produženja QTc intervala povezanog s metabolitom DM-6705, ukoliko je nužna istodobna primjena delamanida i ritonavira, preporučuje se učestalo praćenje
− The tablet coating is composed of: hypromellose, titanium dioxide, macrogols, hydroxypropyl cellulose, talc, colloidal anhydrous silica, polysorbate 80. 
Film ovojnica: hipromeloza titanijev dioksid (E171) makrogoli hidroksipropilceluloza talk silicijev dioksid, koloidni, bezvodni polisorbat 80
Increased plasma concentrations of vardenafil (see section 4.4. and 4.5). 
Povišena koncentracija vardenafila u plazmi (vidjeti dio 4.4 i 4.5).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING NORVIR FILM-COATED TABLETS BOTTLE LABEL TEXT - 3 BOTTLES 
PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU TEKST NA NALJEPNICI NA BOCI NORVIR FILMOM OBLOŽENIH TABLETA- 3 BOCE
Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent induces oxidation by CYP2C9 and glucuronidation and as a result is expected to decrease the plasma concentrations of anticonvulsants. 
Ritonavir doziran kao antiretrovirusni lijek ili kao farmakokinetički pojačivač inducira oksidaciju posredovanu enzimom CYP2C9 i glukuronidaciju, zbog čega se očekuje smanjenje koncentracije antikonvulziva u plazmi.
In a study completed in 1996 recruiting less advanced HIV-1 infected patients (CD4 200-500 cells/µl) without previous antiretroviral therapy, ritonavir in combination with zidovudine or alone reduced viral load in plasma and increased CD4 count. 
200-500 stanica/µl) bez prethodnog antiretrovirusnog liječenja, ritonavir u kombinaciji sa zidovudinom i ritonavir u monoterapiji, smanjio je broj virusnih čestica u plazmi i povećao broj CD4
Based on cross-study comparison to 600 mg saquinavir three times daily alone. 
4. Zasniva se na usporedbi među ispitivanjima sa 600 mg sakvinavira triput na dan, u monoterapiji.
Twice Daily Dose 300 mg/m2 
Doziranje dva puta na dan 300 mg/m²
The co-administration of vorapaxar with Norvir is not recommended (see section 4.4 and refer to the vorapaxar SmPC). 
Istodobna primjena vorapaksara i lijeka Norvir se ne preporučuje (vidjeti dio 4.4 i Sažetak opisa svojstava lijeka za vorapaksar).
For administration using a feeding tube follow the instructions in section ‘How do I take the correct dose of Norvir powder for oral suspension mixed with liquid?' 
Za primjenu putem cjevčice za hranjenje slijedite upute u dijelu „Kako uzeti točnu dozu
Very common Arthralgia and back pain Common Myositis, rhabdomyolysis, myalgia, myopathy/CPK increased 
Često Miozitis, rabdomioliza, mialgija, miopatija/povišenje CK
Place empty sachet in rubbish. 
Korak 9. Praznu vrećicu odložite u smeće.
100 q24h 
100 svakih 24h
You may also notice irregular uterine bleeding if you are taking this type of hormonal contraceptive with Norvir. 
Uzimate li tu vrstu hormonskog kontraceptiva i Norvir, možda primijetite da je i menstrualno krvarenje postalo neredovito.
- Colchicine (for gout) as Norvir may raise the blood levels of this medicine. 
Kolhicin (za liječenje gihta) jer Norvir može povisiti razine ovog lijeka u krvi.
− atovaquone, a medicine used to treat a certain type of pneumonia and malaria; 
− atovakon, lijek koji se koristi za liječenje određenih vrsta upale pluća i malarije; − buprenorfin, koji se koristi za liječenje kronične boli;
Twice Daily Dose 350 mg/m2 
Doziranje dva puta na dan 350 mg/m²
Adverse reactions of nausea, dizziness, hypotension and syncope have been observed in single dose interaction studies in healthy volunteers (see section 4.5) 
U ispitivanjima interakcija pri primjeni jednokratnih doza zdravim dobrovoljcima uočene su nuspojave poput mučnine, omaglice, hipotenzije i sinkope (vidjeti dio 4.5).
Co-administration of fosamprenavir with ritonavir in doses greater than 100 mg twice daily has not been clinically evaluated. 
Fosamprenavir Primjena fosamprenavira istodobno s ritonavirom u dozama većim od većim od 100 mg dva puta na dan nije klinički evaluirana.
Refer to the darunavir Summary of Product Characteristics for further information on once daily dosing in ART experienced patients. 
Za više informacija o doziranju jedanput na dan kod bolesnika koji su prethodno primali ART treba pročitati
HMG-CoA reductase inhibitors which are highly dependent on CYP3A metabolism, such as lovastatin and simvastatin, are expected to have markedly increased plasma concentrations when co-administered with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer. 
koji su izrazito ovisni o metabolizmu posredovanom enzimima CYP3A , poput lovastatina i simvastatina, znatno povećati pri njihovoj istodobnoj primjeni s ritonavirom doziranim kao antiretrovirusnim lijekom ili kao farmakokinetičkim pojačivačem.
b. Point the syringe into the mixing cup and slowly push the plunger to the correct ml for the dose (see Figure 10). 
Usmjerite štrcaljku u čašu za miješanje i polako potiskujte klip do točne doze u mililitrima
Thereby, increasing the risk of arrhythmias or other serious adverse reactions from these agents. 
Time se povećava rizik od aritmija i od ostalih ozbiljnih nuspojava tih lijekova.
500 mg in the morning and 500 mg in the evening 
500 mg ujutro i 500 mg navečer
- Bosentan, riociguat (used for pulmonary arterial hypertension) as Norvir may increase the blood levels of this medicine. 
− Bosentan, riocigvat (lijekovi za plućnu arterijsku hipertenziju) jer Norvir može povisiti razinu tog lijeka u krvi.
Dose of Coadministered Medicinal Products (mg) 
Doza istodobno primijenjeno g lijeka (mg)
Concomitant use of sildenafil for the treatment of erectile dysfunction, with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer should be used with caution and in no instance should sildenafil doses exceed 25 mg in 48 hours (see also section 4.4). 
Pri primjeni sildenafila za liječenje erektilne disfunkcije istodobno s ritonavirom doziranim kao antiretrovirusnim lijekom ili kao farmakokinetičkim pojačivačem nužan je oprez, a sildenafil se ni u kojem slučaju ne smije davati u dozama većima od 25 mg u 48 sati
Method of administration 
Sustav organa
Tel: +39 06 928921 
AbbVie S.r.l. Tel: + 39 06 928921
262.5 mg (26.4 ml) twice daily 
262,5 mg (26,4 ml) dva puta na dan
Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term exposure to combination antiretroviral therapy (CART). 
uznapredovalom HIV-infekcijom i u bolesnika na dugotrajnom kombiniranom antiretrovirusnom liječenju (CART).
AbbVie s.r.o. 
AbbVie B.V.
- The other ingredients are copovidone; sorbitan laurate; silica, colloidal anhydrous. 
− Drugi sastojci su kopovidon, sorbitanlaurat, bezvodni, koloidni silicijev dioksid.
Calcium hydrogen phosphate, anhydrous Silica, colloidal anhydrous Sodium stearyl fumarate 
Tableta: kopovidon sorbitanlaurat kalcijev hidrogenfosfat, bezvodni silicijev dioksid, koloidni, bezvodni natrijev stearilfumarat
Important information regarding medicinal product interactions when ritonavir is used a pharmacokinetic enhancer is also contained in the Summary of Product Characteristics of the coadministered protease inhibitor. 
Važne informacije o interakcijama među lijekovima kada se ritonavir daje kao farmakokinetički pojačivač mogu se naći i u Sažetku opisa svojstava lijeka za inhibitor proteaze koji se istodobno primjenjuje.
Twice Daily Dose 250 mg/m2 
Doziranje dva puta na dan 250 mg/m²
See section 4.4 and section 4.5 for co-administration of sildenafil in patients with erectile dysfunction. 
(vidjeti dio 4.4 i Sažetak opisa svojstava lijeka za vorapaksar).
500 q12h 
500 svakih 12h
Reduction in the antiretroviral activity of ritonavir is primarily associated with the protease mutations V82A/F/T/S and I84V. 
Smanjenje antiretrovirusne aktivnosti ritonavira prvenstveno je povezano s mutacijama proteaze
Uncommon Increased glucose, increased magnesium, increased alkaline phosphatase 
Često Povišena vrijednost amilaze, snižene vrijednosti slobodnog i ukupnog tiroksina Manje često Povišena vrijednost glukoze, povišena vrijednost magnezija, povišena vrijednost alkalne fosfataze
300 mg in the morning and 300 mg in the evening 
300 mg ujutro i 300 mg navečer
Children and adolescents (2 years of age and above) The recommended dosage of Norvir in children is 350 mg/m² by mouth twice daily and should not exceed 600 mg twice daily. 
Preporučena doza lijeka Norvir u djece je 350 mg/m2 dva puta na dan kroz usta, a doza ne smije premašiti 600 mg dva puta na dan.
− The other tablet ingredients are: copovidone, sorbitan laurate, anhydrous calcium hydrogen phosphate, colloidal anhydrous silica, sodium stearyl fumarate. 
Drugi sastojci u tableti su: kopovidon, sorbitanlaurat, bezvodni kalcijev hidrogenfosfat,
100, single dose 500 q12h 
5, jednokratna doza 400 svakih 12h
If the dates for submission of a PSUR and the update of a RMP conincide, they can be submitted at the same time. 
Plana (RMP), dokumenti mogu biti podneseni istodobno.
400 mg in the morning and 300 mg in the evening 
400 mg ujutro i 300 mg navečer
500 mg in the morning and 400 mg in the evening 
500 mg ujutro i 400 mg navečer
Abnormal liver function tests, hepatitis (inflammation of the liver), and rarely jaundice, have been reported in patients taking Norvir. 
U bolesnika koji su uzimali Norvir bilo je prijava poremećenih nalaza jetrene funkcije, hepatitisa (upala jetre) i rijetko žutice.
↑ 4-fold 
Gospina trava
What you need to know before you or your child takes Norvir. 
Što morate znati prije nego što Vi ili Vaše dijete počnete uzimati Norvir.